Article
New treatment strategies for Waldenström macroglobulinemia.
Clinical advances in hematology & oncology : H&O - 1 Aug 2022
Moreno David F, de Larrea Carlos Fernández, Castillo Jorge J
Abstract excerpt
The development of high-throughput technologies has allowed us to characterize the molecular landscape of hematologic neoplasms and identify somatic mutations. As a result, we can now use these technologies to screen for and diagnose neoplastic disease, model risk factors for progression, make treatment decisions, track response to treatment, and design clinical trials. Waldenström macroglobulinemia (WM), which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
